What the gut-skin axis actually is
The gut and skin are, superficially, very different organs. But they share important characteristics: both are interfaces between the body and its external environment, both host complex microbial communities, both have significant immune activity embedded in their structure, and both are directly affected by the state of systemic inflammation.
The gut-skin axis refers to the bidirectional communication network between these two systems, primarily via immune mediators, microbial metabolites, and the systemic inflammatory signals that travel through the bloodstream. Disruption to the gut microbiome, breakdown of the intestinal barrier, and the resulting systemic immune activation do not stay confined to the digestive system. They travel, and the skin, as a highly immunologically active organ with its own resident bacteria, is one of the most responsive downstream targets.
This is not to say that every skin condition is caused by gut problems, or that gut intervention will resolve every skin condition. But for a significant proportion of people with inflammatory skin conditions, the gut is an upstream driver that has not been addressed. The skin has been treated as the primary problem rather than as a symptom of something systemic.
How the gut drives skin inflammation
When the gut barrier is compromised, undigested food proteins, bacterial fragments, and lipopolysaccharide (LPS), a component of gram-negative bacterial cell walls, enter the bloodstream. LPS is a potent immune activator that triggers systemic inflammatory cascades, including elevated levels of TNF-α, IL-6, and IL-1β. These cytokines circulate systemically and activate inflammatory pathways in the skin, contributing to the inflammatory microenvironment in which eczema, acne, rosacea, and psoriasis are maintained and exacerbated.
The gut microbiome regulates immune tone systemically, including the Th1/Th2 balance that determines whether the immune system defaults toward allergic and inflammatory responses or toward regulatory, tolerant responses. Gut dysbiosis, particularly a depletion of the regulatory T-cell-promoting species like Lactobacillus rhamnosus and various Bifidobacteria, shifts this balance toward a Th2-dominant state that predisposes to atopic conditions including eczema and food allergies. The gut microbiome also produces short-chain fatty acids, particularly butyrate, that directly regulate immune cell differentiation and reduce systemic inflammatory tone.
Psychological stress activates the HPA axis and increases cortisol, which simultaneously increases intestinal permeability, alters the gut microbiome composition, and activates mast cells in the skin. This three-way connection between stress, gut permeability, and skin inflammation explains the consistent clinical observation that stress flares both gut symptoms and skin conditions simultaneously, as they share the same upstream trigger.
"The gut and the skin share a common upstream: the systemic immune and inflammatory environment shaped by what the gut allows through its wall."
Gut and eczema
Atopic eczema has the strongest and most established gut-skin connection in the research literature. Studies consistently find that infants and adults with eczema have reduced microbiome diversity, lower levels of butyrate-producing species, and altered Th1/Th2 immune balance compared to non-atopic controls. The link appears to begin early: antibiotic use in infancy, which disrupts the microbiome at a critical window for immune development, is associated with a significantly increased risk of atopic eczema.
For adults with eczema, particularly those who notice flares associated with specific foods, stress, or antibiotic courses, the gut-skin axis is likely a meaningful contributor. Gut lining support that reduces the antigen load entering systemic circulation can produce meaningful skin improvement within four to eight weeks in people with permeability-driven skin inflammation.
Gut and acne
The link between gut health and acne has been hypothesised since the 1930s, when Stokes and Pillsbury proposed that gut dysbiosis drives the systemic inflammation and sebaceous gland dysfunction that characterise acne. The "forgotten gut-brain-skin axis" connection they described has since been substantially supported by microbiome research.
People with acne have measurably different gut microbiome compositions compared to clear-skinned controls, with lower levels of Lactobacillus and higher levels of inflammatory species. They also have elevated intestinal permeability markers and higher circulating levels of LPS-associated inflammatory proteins. Studies using oral probiotics, particularly Lactobacillus acidophilus and Lactobacillus bulgaricus, have shown significant reductions in acne lesion counts after twelve weeks, suggesting the microbiome connection is not merely correlative.
Acne is also exacerbated by dietary patterns that directly affect the gut. High glycaemic index diets alter the gut microbiome in ways that increase propionibacterial activity, and dairy consumption, particularly skimmed milk, is associated with increased acne severity through hormonal and inflammatory pathways that include gut-mediated mechanisms.
Gut and rosacea
Rosacea has the most striking gut association of any inflammatory skin condition. A large epidemiological study found that rosacea patients have significantly higher rates of gastrointestinal diagnoses, particularly SIBO, H. pylori infection, inflammatory bowel disease, and coeliac disease, than the general population. A separate study found that 54 per cent of rosacea patients tested positive for SIBO compared to 3 per cent of controls.
The clinical implication is important: in the SIBO study, treating the overgrowth with rifaximin produced significant rosacea improvement in 96 per cent of patients, and complete remission in 64 per cent, maintained at three-year follow-up. This is a stronger treatment effect than most topical rosacea therapies produce, and in a substantial proportion of patients it appears to have addressed the primary driver rather than just suppressing the skin symptom.
Gut and psoriasis
Psoriasis is a T-cell-mediated inflammatory condition characterised by excessive keratinocyte proliferation. People with psoriasis have two to three times the rate of inflammatory bowel disease of the general population, and the microbiome alterations found in psoriasis closely resemble those found in Crohn's disease, suggesting shared dysbiotic drivers rather than coincidental overlap.
Studies of intestinal permeability in psoriasis patients find significantly elevated permeability markers, and the degree of permeability elevation correlates with psoriasis severity scores. Anti-inflammatory dietary interventions that support gut barrier function, such as low-glycaemic, high-fibre diets avoiding emulsifiers and alcohol, show consistent benefits in psoriasis severity, consistent with the gut lining as an upstream contributor to systemic inflammatory tone.
Addressing the gut-skin axis
The practical approach to the gut-skin axis is the same as for any gut lining and microbiome-focused intervention, but with an awareness that the skin response may lag behind the gut changes by two to four weeks. Gut lining improvement typically shows in digestive symptoms first, with skin changes following as systemic antigen load reduces and inflammatory tone settles.
- Address gut lining permeability with the ingredients that have the clearest evidence: L-Glutamine, DGL licorice, marshmallow root, and slippery elm. The reduction in systemic antigen load as the barrier improves is the primary mechanism through which gut lining support produces skin benefits.
- Support the microbiome with diverse plant fibre (aiming for 30 different plant sources weekly) and spore-forming probiotics. The Th1/Th2 rebalancing that gut microbiome restoration produces takes three to six months to produce durable immune shifts.
- Remove dietary triggers that directly compromise the gut lining: alcohol, emulsifier-heavy ultra-processed foods, and for those with identifiable reactions, high-FODMAP foods during the recovery period.
- Manage stress explicitly. The shared gut-skin stress response means that gut lining support in the presence of unmanaged chronic stress works against a headwind. Stress management is mechanistically relevant, not peripheral.
- Expect a two to four month window before meaningful skin improvement. Gut lining repair produces skin changes on a longer lag than gut symptom improvement. Consistency over this window is more important than chasing early signs of change.
Research-grounded gut health, in your inbox
We write about gut lining support, the microbiome, and what the evidence actually says, without the wellness noise.
No spam. Unsubscribe any time.